GE HealthCare Technologies Inc.
$71.58
▼
-0.94%
2026-04-22 10:12:13
www.gehealthcare.com
NMS: GEHC
Explore GE HealthCare Technologies Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$32.85 B
Current Price
$71.58
52W High / Low
$89.77 / $59.95
Stock P/E
15.76
Book Value
$22.77
Dividend Yield
0.19%
ROCE
9.93%
ROE
22.38%
Face Value
—
EPS
$4.55
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
54,000
Beta
1.3
Debt / Equity
98.72
Current Ratio
1.37
Quick Ratio
1.13
Forward P/E
13.18
Price / Sales
1.62
Enterprise Value
$39.54 B
EV / EBITDA
10.86
EV / Revenue
1.92
Rating
Buy
Target Price
$91.74
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Beyond Air, Inc. | $0.55 | — | $6.22 M | — | -177.71% | -2.4% | $5.84 / $0.43 | $0.96 |
| 2. | Zimmer Biomet Holdings, Inc. | $94.32 | 26.61 | $18.29 B | 1.04% | 6.61% | 5.6% | $108.29 / $84.59 | $64.95 |
| 3. | Lucid Diagnostics Inc. | $1.3 | — | $221.18 M | — | -418.44% | -7.11% | $1.7 / $0.95 | $-0.33 |
| 4. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 5. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 6. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 7. | NovoCure Limited | $12.67 | — | $1.44 B | — | -26.47% | -38.89% | $20.06 / $9.82 | $3.03 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.7 B | 5.14 B | 5.01 B | 4.78 B | 5.32 B | — |
| Operating Profit | 827 M | 653 M | 654 M | 628 M | 801 M | — |
| Net Profit | 589 M | 446 M | 486 M | 564 M | 721 M | — |
| EPS in Rs | 1.29 | 0.98 | 1.07 | 1.24 | 1.58 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 20.62 B | 19.67 B | 19.55 B | 18.34 B |
| Operating Profit | 2.76 B | 2.62 B | 2.44 B | 2.52 B |
| Net Profit | 2.08 B | 1.99 B | 1.57 B | 1.92 B |
| EPS in Rs | 4.57 | 4.37 | 3.44 | 4.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 36.91 B | 33.09 B | 32.45 B | 27.54 B |
| Total Liabilities | 26.31 B | 24.44 B | 25.14 B | 17.95 B |
| Equity | 10.38 B | 8.45 B | 7.13 B | 9.36 B |
| Current Assets | 12.5 B | 9.9 B | 9.41 B | 8.32 B |
| Current Liabilities | 9.11 B | 9.55 B | 8.98 B | 7.19 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.99 B | 1.95 B | 2.1 B | 2.11 B |
| Investing CF | -1.05 B | -914 M | -558 M | -398 M |
| Financing CF | 617 M | -573 M | -478 M | -822 M |
| Free CF | 1.5 B | 1.55 B | 1.71 B | 1.8 B |
| Capex | -482 M | -401 M | -387 M | -310 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.61% | 6.6% | — | — |
| Earnings Growth % | 27.1% | -18.16% | — | — |
| Profit Margin % | 10.13% | 8.02% | 10.45% | — |
| Operating Margin % | 13.34% | 12.45% | 13.75% | — |
| Gross Margin % | 41.71% | 40.52% | 39.14% | — |
| EBITDA Margin % | 18.64% | 17.97% | 17.62% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-04-02 | $0.035 |
| 2026-01-09 | $0.035 |
| 2025-10-24 | $0.035 |
| 2025-07-25 | $0.035 |
| 2025-04-25 | $0.035 |
Stock Splits
No stock split history available.